The relative ability of 44 To use erythromycin as a probe of topological relationships on the ribosome, some erythromycin analogues were synthesized. These analogues permit us to determine which areas of the erythromycin molecule could be modified with retention of ability to bind to ribosomes. Since it was not convenient to synthesize each analogue in radioactive form, the relative activity of each analogue was determined by its effect on [14C] By using a cell-free system for studying the relative binding activity of erythromycin analogues rather than studying their effect on intact bacteria, variations in transport, solubility, permeability, degradation, and modification are excluded. 
ribosomes. The association and dissociation constants of each of these erythromycin derivatives were 9 .0001 the association constant of erythromycin were detectable. This assay could be used alone or in conjunction with microbiological assays for primary screening of active analogues or other compounds which interfere with
[I4C]erythromycin binding to ribosomes. It permits an estimate of the general activity of compounds rapidly and directly. Variables such as metabolic modifications of the compounds and permeability are excluded. The present assay reflects the ability of the compounds to interact directly with their target organelle and may serve as a useful adjunct in developing new compounds.
To use erythromycin as a probe of topological relationships on the ribosome, some erythromycin analogues were synthesized. These analogues permit us to determine which areas of the erythromycin molecule could be modified with retention of ability to bind to ribosomes. Since it was not convenient to synthesize each analogue in radioactive form, the relative activity of each analogue was determined by its effect on [14C]erythromycin binding to ribosomes. Such studies allow us to determine in which areas of the erythromycin molecule we could attach reactive groups for affinity labeling of ribosomal components. Reactive groups with radioactive labels could be attached to different areas of erythromycin. The ribosomal proteins or oligonucleotides to which these labels become linked should comprise the erythromycin binding site. Furthermore, it may be possible to cross-link proteins by the use of two or more reactive groups on a single erythromycin molecule. By extension of these techniques, it should be possible to develop a topological map of the erythromycin binding site and adjacent areas.
By using a cell-free system for studying the relative binding activity of erythromycin analogues rather than studying their effect on intact bacteria, variations in transport, solubility, permeability, degradation, and modification are excluded. Thus, the relative activity of the above analogues on [CIC] erythromycin A (45.7 mCi/mmol) was synthesized as described in the accompanying communication (10) . Ribosomes were prepared as described previously (9 27 R -R'-R"-H 28 R R'-CH3CO-, R"sH 29 RxR'mH, R"-CH3CO-30 R-R' H, R"aCH3CH2CO-31 R a R'=H, R"-C6H50O-32 R * R' CH3CO-, R*-C6H5CO- Known analogues in which the desosamine moiety has been modif'ied include compounds 3 to 6. When the dimethylamino group was eliminated and a double bond introduced between C-3' and C-4' (3) (4), the activity of' the compound in ability to inhibit ['4C ]ervthromcin binding to ribosomes was reduced to approximately 1/130 that of erythromycin A. When an epoxide is present between carbons 3' and 4' (6) (3), the activity was further reduced to less than 1/2,000 the activity of erythromycin A. The compound was essentially inactive. When the dimethylamino group was converted into an N-oxide (4) (4), the compound retained substantial activity; it was about 1/50 as active as erythromycin A. Mao and Putterman (7) reported no activity for the N-oxide under the condition of their assay. Acetylation of the 2'-hydroxyl group (5) (12) erythromycin; 7.5 absorbancy units of NH4Cl-washed ribosomes at 260 nm; and erythromycin analogues at the concentrations indicated on the abscissas. Reactions were started by the addition of ribosomes and incubated at 24 C for 30 min. In the case of analog 28, the reaction was incubated at 24 C for 15 min to minimize hydrolysis of the erythromycin derivative. Assays were performed as described. The data are presented as a percentage of the ["4CJerythromycin bound to ribosomes in the absence of any nonradioactive, erythromycin or erythromycin derivatives. erythromycin A in inhibiting erythromycin binding to ribosomes. Enlarging the size of the aliphatic group to a pentyl moiety (11) also enhanced the activity compared to the underivatized oxime; the compound was approximately one-third to one-half as active as erythromycin A. However, enlarging the size of the aliphatic group to a nonyl residue (12) reduced the activity of the compound greatly; this compound was approximately 1/150 as active as erythromycin A. On the other hand, substitution of the oxime with a benzyl moiety (13) resulted in a derivative which was one-third to one-half as active as erythromycin A, although it was slightly more active than the underivatized oxime.
It has been possible to remove the cladinose residue from erythromycin A (R. A. LeMahieu, M. Carson, R. W. Kierstead, L. M. Fern, and E. Grunberg, J. Med. Chem., in press). Some analogues were then prepared with various substituents on the hydroxyl group at C-3. The oxime derivative of erythromycin A in which cladinose was removed (27) was about 1/385 as active as erythromycin A. Acetylation of the oxime and the 2'-hydroxyl groups (28) increased the activity of the compound so that it was 1/120 as active as erythromycin A. Acetylation of only the 3-hydroxyl group (29) Determination of association constants for analogues. By using the method of Harris and Pestka (2), it was possible to compute the association (K,) and dissociation (Kd) constants as well as the number of sites (n) on ribosomes for each analogue. In Fig. 7 , the results of representative computations are plotted for several of the erythromycin analogues; and in Table 2 , K,, Kd, pKd, and n are given for each analogue. In general, the pK,0% and pKd values are related to each other (Fig. 8) (6, 7) . In the studies reported in this communication, quantitative binding constants were assigned to these and other even less active derivatives.
Substitutions on various portions of the erythromycin molecule could be made with retention of substantial activity in inhibiting [14C]erythromycin binding to ribosomes. Thus, after removal of cladinose, various substituents can be attached to the 3-hydroxyl group. Also, various substituents can be placed on the oxime of erythromycin A oxime with retention of much activity. Furthermore, the desosamine residue can be modified in at least two places with retention of good activity. Substitutions could be made on the 2'-hydroxyl group as well as on the dimethylamino group. Thus, in at least four separate positions, substantial substitutions were made with retention of activity. It should be possible to incorporate reactive groups for affinity labeling in these various positions singly and in various combinations to provide knowledge about the topological site of interaction of erythromycin A with ribosomes. A molecule carrying such groups in two or more distinct sites on the erythromycin A molecule might be expected to cross-link proteins or other components which comprise or are adjacent to the erythromycin A binding site. Furthermore, by extending the size and length of the groups with reactive moieties at the end, it should be possible to topologically map the ribosomal surface with respect to the erythromycin binding site.
It is apparent that removal of the dimethylamino group from desosamine reduced activity enormously. Structural alterations produced by the introduction of oxygen bridges within the macrolide ring also generally reduced ability to interact with ribosomes (compare analogues 1 and 2). Removal of both cladinose and desosamine groups abolished activity. Substantial activity was retained, however, upon removal of only the cladinose residue. Introduction of a 3-keto group in the macrolide ring essentially abolished activity of the molecule (compare 19 and 28 as well as 20 and 27).
Acetylation of the 3-hydroxyl group increased the activity of 5-O-desosaminylerythronolide A (compare 27 and 29). The activity was further increased by substituents such as a benzoyl or substituted benzoyl group in this position (31, 36, 37, 38, 39). Because of the relatively rapid hydrolysis of acetyl substituents on the oxime and 2'-hydroxyl group, it was necessary to evaluate these compounds only when freshly dissolved in aqueous solutions. If (11) . The present assay reflects the ability of the compounds to interact directly with their target organelle and may serve as a useful adjunct in developing new compounds.
